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Abstract
Background
Quality standards (QS) for people with multiple sclerosis (PwMS) are suboptimal, ambiguous
and restricted to certain patient subgroups and care pathways.
Aim
Develop and pilot MS metrics measuring service provision quality to identify areas for
improvement.
Methods
A multidisciplinary Working Group developed clinician and patient-reported metrics and
standardised data collection forms through an iterative process.
Results
Metrics covered: referral; diagnosis; treatment; annual review; general management; education.
Pilot (n=76) showed: 31% of PwMS were referred to MS specialist within 4 weeks of
suspected/confirmed demyelination; 28% and 56% had uncomplicated MS confirmed and were
offered specialist MS nurse appointment, respectively, within 4 weeks of specialist referral; 75%
of eligible PwMS were offered disease-modifying therapy within 8 weeks of confirmed MS
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diagnosis; 85% had comprehensive multidisciplinary team (MDT) annual review; 90% had a
defined point of contact within the MS service; 86% of unscheduled contacts by PwMS, MDT or
general practitioners were responded to within 3 days; 53% of MS services maintained a single
database of PwMS; and 76% of PwMS were offered ongoing education. Data collection
continues and updated findings will be reported.
Discussion
MS metrics/data forms are feasible for routine clinical settings, simple to interpret and provide
a valuable benchmark for guiding MS service improvements.
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